Gyanu Lamichhane

5.1k total citations
93 papers, 3.9k citations indexed

About

Gyanu Lamichhane is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Gyanu Lamichhane has authored 93 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 68 papers in Infectious Diseases and 28 papers in Molecular Biology. Recurrent topics in Gyanu Lamichhane's work include Tuberculosis Research and Epidemiology (68 papers), Mycobacterium research and diagnosis (59 papers) and Antibiotic Resistance in Bacteria (24 papers). Gyanu Lamichhane is often cited by papers focused on Tuberculosis Research and Epidemiology (68 papers), Mycobacterium research and diagnosis (59 papers) and Antibiotic Resistance in Bacteria (24 papers). Gyanu Lamichhane collaborates with scholars based in United States, South Africa and Brazil. Gyanu Lamichhane's co-authors include William R. Bishai, Radhika Gupta, Elizabeth Story‐Roller, J Grosset, Scott T. Nolan, Eric L. Nuermberger, Sanjay K. Jain, Sandeep Tyagi, Amit Kaushik and Petros C. Karakousis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gyanu Lamichhane

88 papers receiving 3.8k citations

Peers

Gyanu Lamichhane

EPIDE

Anil Koul Belgium

Khisimuzi Mdluli United States

Ken Duncan United Kingdom

Richard A. Slayden United States

James C. Sacchettini United States

Martin Gengenbacher United States

Bavesh D Kana South Africa

Sarah A. Stanley United States

Ramandeep Singh India

Alain R. Baulard France

Anil Koul Belgium

Gyanu Lamichhane

3.1k ×1.2

2.0k ×1.0

EPIDE

2.8k ×1.9

578 ×0.8

539 ×1.2

Citations per year, relative to Gyanu Lamichhane Gyanu Lamichhane (= 1×) peers Anil Koul

Countries citing papers authored by Gyanu Lamichhane

Since Specialization

Citations

This map shows the geographic impact of Gyanu Lamichhane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gyanu Lamichhane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gyanu Lamichhane more than expected).

Fields of papers citing papers by Gyanu Lamichhane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gyanu Lamichhane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gyanu Lamichhane. The network helps show where Gyanu Lamichhane may publish in the future.

Co-authorship network of co-authors of Gyanu Lamichhane

This figure shows the co-authorship network connecting the top 25 collaborators of Gyanu Lamichhane. A scholar is included among the top collaborators of Gyanu Lamichhane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gyanu Lamichhane. Gyanu Lamichhane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lamichhane, Gyanu, et al.. (2025). The efficacy of a regimen comprising clarithromycin, clofazimine, and bedaquiline in a mouse model of chronic Mycobacterium avium lung infection. Antimicrobial Agents and Chemotherapy. 69(4). e0185324–e0185324.

Thomas, B., et al.. (2025). Synthesis and antibacterial activity of novel benzodioxin-containing oxazolidinones against M. abscessus. Bioorganic & Medicinal Chemistry Letters. 128. 130359–130359.

Dartois, Véronique, Tracey L. Bonfield, Charles L. Daley, et al.. (2024). Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations. Tuberculosis. 147. 102503–102503. 12 indexed citations

Wang, Wen, et al.. (2024). Oral oxaborole MRX-5 exhibits efficacy against pulmonary Mycobacterium abscessus in mouse. Antimicrobial Agents and Chemotherapy. 68(11). e0135124–e0135124. 2 indexed citations

Ignatius, Elisa H., et al.. (2024). Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease. Tuberculosis. 146. 102482–102482. 5 indexed citations

Jager, Veronique de, Nikhil Gupte, Sílvia Nunes, et al.. (2022). Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 205(10). 1228–1235. 23 indexed citations

Gallardo‐Macias, Ricardo, et al.. (2021). Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection. PLoS ONE. 16(5). e0249841–e0249841. 2 indexed citations

Story‐Roller, Elizabeth, Evan P. Lloyd, Amit Kaushik, et al.. (2020). Development of a penem antibiotic against Mycobacteroides abscessus. Communications Biology. 3(1). 741–741. 13 indexed citations

Story‐Roller, Elizabeth, et al.. (2019). Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro. Antimicrobial Agents and Chemotherapy. 63(4). 51 indexed citations

10.

Kaushik, Amit, Nicole C. Ammerman, Barry N. Kreiswirth, et al.. (2019). In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Antimicrobial Agents and Chemotherapy. 63(3). 53 indexed citations

11.

Govender, Thavendran, Glenn E. M. Maguire, Gyanu Lamichhane, et al.. (2017). Differential flap dynamics in l , d -transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics. Molecular BioSystems. 13(6). 1223–1234. 36 indexed citations

12.

Islam, Md. Mahmudul, H. M. Adnan Hameed, Chiranjibi Chhotaray, et al.. (2016). Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of genetics and genomics. 44(1). 21–37. 66 indexed citations

13.

Pelly, Shaaretha, et al.. (2016). REMap: Operon map of M. tuberculosis based on RNA sequence data. Tuberculosis. 99. 70–80. 6 indexed citations

14.

Kumar, Pankaj, Amit Kaushik, Evan P. Lloyd, et al.. (2016). Non-classical transpeptidases yield insight into new antibacterials. Nature Chemical Biology. 13(1). 54–61. 111 indexed citations

15.

Kaushik, Amit, et al.. (2015). Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 59(10). 6561–6567. 98 indexed citations

16.

Alves, Cláudio Nahum, Thavendran Govender, Hendrik G. Kruger, et al.. (2015). Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. Tuberculosis. 95(2). 95–111. 53 indexed citations

17.

Olaleye, Omonike A., Tirumalai R. Raghunand, Shridhar Bhat, et al.. (2010). Methionine Aminopeptidases from Mycobacterium tuberculosis as Novel Antimycobacterial Targets. Chemistry & Biology. 17(1). 86–97. 53 indexed citations

18.

Davis, S. Lindsey, Nicholas A. Be, Gyanu Lamichhane, et al.. (2009). Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals. PLoS ONE. 4(7). e6297–e6297. 52 indexed citations

19.

Jain, Sanjay K., Qijian Cheng, Prabhpreet Singh, et al.. (2007). Accelerated Detection ofMycobacterium tuberculosisGenes Essential for Bacterial Survival in Guinea Pigs, Compared with Mice. The Journal of Infectious Diseases. 195(11). 1634–1642. 38 indexed citations

20.

Karakousis, Petros C., Tetsuyuki Yoshimatsu, Gyanu Lamichhane, et al.. (2004). Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice. The Journal of Experimental Medicine. 200(5). 647–657. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact